Life sciences news
-
UCB’s Board of Directors appoints Jonathan Peacock as new Chair
Thursday March 9th 2023
Read more
-
Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates
Thursday March 9th 2023
Read more
-
Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America
Monday March 6th 2023
Read more
-
VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology
Thursday March 2nd 2023
Read more
-
Confo Therapeutics announces Global Licensing Agreement with Lilly for peripheral pain candidate, CFTX-1554
Thursday March 2nd 2023
Read more
-
Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test
Thursday March 2nd 2023
Read more
-
CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease
Thursday March 2nd 2023
Read more
-
Mithra announces compelling initial preclinical data in its research collaboration on novel tyrosine kinase inhibitors with BCI Pharma
Thursday March 2nd 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Oxurion announces subscription agreement with Atlas providing the company with up to €20 million in funding
Thursday March 2nd 2023
Read more
-
New biostimulant seed treatment set to boost wheat yields with reduced fertilizer use
Wednesday March 1st 2023
Read more
-
Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure
Wednesday March 1st 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
